Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease

Published:2018 Issue:1 Volume:140 Page:48-57
ISSN:1660-8151
Container-title:Nephron
language:en
Short-container-title:Nephron

Author:

Gritter Martin,Vogt Liffert,Yeung Stanley M.H.,Wouda Rosa D.,Ramakers Christian R.B.,de Borst Martin H.,Rotmans Joris I.,Hoorn Ewout J.

Publisher

S. Karger AG

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potassium puzzle: exploring the intriguing connection to albuminuria;Frontiers in Nutrition;2024-05-27

2. Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death;Journal of Hypertension;2023-12-14

3. Potassium intake: the Cinderella electrolyte;European Heart Journal;2023-11-04

4. Chronic kidney disease increases the susceptibility to negative effects of low and high potassium intake;Nephrology Dialysis Transplantation;2023-10-09

5. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up;American Journal of Kidney Diseases;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP